Brad Herskowitz
Impact in
- Psychiatry and Mental health top 2%
- Dementia and Cognitive Impairment Research
- Physiology top 2%
- Alzheimer's disease research and treatments
Papers in
-
- Alzheimer's disease research and treatments 7
- Genetics 3
- Mesenchymal stem cell research 3
- Co-authors
- Daniel M. Lichtstein (1 shared paper)Gary W. Small (1 shared paper)Zhijie Jiang (1 shared paper)Anthony A. Oliva (4 shared papers)Felipe Sierra (1 shared paper)Susan Y. Bookheimer (3 shared papers)Kevin N. Ramdas (3 shared papers)Bruno J. Vellas (1 shared paper)
- Journals
- Alzheimer s & Dementia (4 papers)The Journal of Prevention of Alzheimer s Disease (1 paper)Nature Medicine (1 paper)JAMA (1 paper)Southern Medical Journal (1 paper)
- Partner nations
- United StatesFranceSouth Korea
In The Last Decade
Brad Herskowitz
7 papers receiving 1.8k citations
Brad Herskowitz's Hit Papers
Peers
Comparison fields: 5 of 79
- Psychiatry and Mental health 839
- Physiology 1k
- Neurology 94
- Neurology 72
- Developmental Neuroscience 16
Countries citing papers authored by Brad Herskowitz
This map shows the geographic impact of Brad Herskowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brad Herskowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brad Herskowitz more than expected).
Fields of papers citing papers by Brad Herskowitz
This network shows the impact of papers produced by Brad Herskowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brad Herskowitz. The network helps show where Brad Herskowitz may publish in the future.
Co-authors
The 23 scholars most cited alongside Brad Herskowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Donanemab in Early Symptomatic Alzheimer Disease Hit paper breakdown → | 2023 | 1799 |
| 2 | 2022 | 54 | |
| 3 | Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer’s disease: a randomized controlled phase 2a trial Hit paper breakdown → | 2025 | 34 |
| 4 | 1998 | 8 | |
| 5 | 2021 | 7 | |
| 6 | 2024 | 2 | |
| 7 | 2020 | 1 | |
| 8 | 2025 | 0 |
About Brad Herskowitz
Brad Herskowitz is a scholar working on Physiology, Genetics, Surgery, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 8 papers that have together received 1.9k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (7 papers), Mesenchymal stem cell research (3 papers) and Gastrointestinal disorders and treatments (1 paper). The work is most often cited by research in Psychiatry and Mental health (839 citations), Physiology (1k citations), Neurology (94 citations), Neurology (72 citations) and Developmental Neuroscience (16 citations). Brad Herskowitz has collaborated with scholars based in United States, France and South Korea. Frequent co-authors include Daniel M. Lichtstein, Gary W. Small, Zhijie Jiang, Anthony A. Oliva, Felipe Sierra, Susan Y. Bookheimer, Kevin N. Ramdas, Bruno J. Vellas, Katalina McInerney and Joshua M. Hare. Their work appears in journals such as Alzheimer s & Dementia, The Journal of Prevention of Alzheimer s Disease, Nature Medicine, JAMA and Southern Medical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.